In a clinical study, Li et al. found that the serum level of IL-9 in patients with IPF during infection phase was significantly higher than that in the stable phase and healthy controls, suggesting that IL-9 is a risk factor for patients with IPF [26]. Here, IL9 is linked to idiopathic pulmonary fibrosis.